StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) stock

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 7/30
$270.33−0.86 (-0.32%)

Close on Nov 18, 2026Market cap $16.75BP/E 22.2Yield –

Ascendis Pharma A/S price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ascendis Pharma A/S's price to sales ratio was 14.1× on Nov 11, 2026, against 17.3× a year earlier. Over the last 5 years it ranged from 12.2× to 431.6×, with a median of 24.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.1×−3.0
2025Dec 31, 202517.2×−6.4
2024Dec 31, 202423.5×−18.5
2023Dec 29, 202342.1×−151.7
2022Dec 30, 2022193.7×−237.9
2020Apr 30, 2020431.6×+155.0
2019Dec 31, 2019276.6×+40.1
2018Jan 31, 2018236.5×+44.3
2017Dec 29, 2017192.2×+136.0
2016Dec 30, 201656.2×–

More Ascendis Pharma A/S figures

See a number that looks wrong?